Brightstar Therapeutics Secures Series A Financing to Propel Groundbreaking Treatment for Corneal Diseases; Appoints Chief Medical Officer and Chief Scientific Officer to Lead
Brightstar Therapeutics, a biotechnology company focused on providing innovative treatment options for corneal and ocular surface diseases, announced the closing of its Series A financing....